Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats

BACKGROUND: Levodopa (l-dopa) remains the best drug in the treatment of Parkinson’s disease (PD). Unfortunately, long-term l-dopa caused motor complications, one of which is l-dopa-induced dyskinesia (LID). The precise mechanisms of LID are not fully understood. We have previously reported that rani...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hongjuan, Yang, Xinxin, Zhao, Hui, Zhang, Shenyang, Zu, Jie, Zhang, Wei, Shen, Xia, Cui, Guiyun, Hua, Fang, Yan, Chuanzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455849/
https://www.ncbi.nlm.nih.gov/pubmed/26064051
http://dx.doi.org/10.2147/NDT.S80174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455849/
https://www.ncbi.nlm.nih.gov/pubmed/26064051
http://dx.doi.org/10.2147/NDT.S80174

Ejemplares similares